Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MFS-16 for induction and maintenance of general anesthesia in elective surgery
CTR20263764Phase 2Active
- Sponsor
- Mafeisan Pharmaceutical
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of MFS-16 (2 arms), sponsored by Mafeisan Pharmaceutical. Primary endpoints: Anesthesia success rate, Safety and tolerability and 1 more. Started Oct 2026; status: active.
02
Drugs
MFS-16
Beyond the preview
Go deeper on CTR20263764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263764.